| Induction chemotherapy and ablative stereotactic magnetic resonance image-guided adaptive radiation therapy for inoperable pancreas cancer MD Chuong, R Herrera, A Kaiser, M Rubens, T Romaguera, D Alvarez, ... Frontiers in Oncology 12, 888462, 2022 | 25 | 2022 |
| CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy LL Rodriguez, R Kotecha, MC Tom, MD Chuong, JA Contreras, ... Radiotherapy and Oncology 166, 101-109, 2022 | 23 | 2022 |
| Dose-escalated magnetic resonance image–guided abdominopelvic reirradiation with continuous intrafraction visualization, soft tissue tracking, and automatic beam gating MD Chuong, JM Bryant, R Herrera, J McCulloch, J Contreras, R Kotecha, ... Advances in Radiation Oncology 7 (2), 100840, 2022 | 13 | 2022 |
| Long-term multi-institutional outcomes of 5-fraction ablative stereotactic mr-guided adaptive radiation therapy (smart) for inoperable pancreas cancer with median prescribed … MD Chuong, C Kirsch, R Herrera, M Rubens, G Gungor, EM Schaff, ... International journal of radiation oncology, biology, physics 111 (3), S147-S148, 2021 | 13 | 2021 |
| Causes of death among patients with initially inoperable pancreas cancer after induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance image guided … MD Chuong, R Herrera, A Ucar, S Aparo, F De Zarraga, H Asbun, ... Advances in Radiation Oncology 8 (1), 101084, 2023 | 8 | 2023 |
| Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART) With Median Biologically Effective Dose of 100 Gy10 for … MD Chuong, R Herrera, TZ Mustafayev, G Gungor, G Ugurluer, B Atalar, ... International journal of radiation oncology, biology, physics 111 (3), e475-e476, 2021 | 8* | 2021 |
| Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstration A La Rosa, KE Mittauer, AE Rzepczynski, MD Chuong, T Kutuk, N Bassiri, ... Medical Dosimetry 48 (3), 127-133, 2023 | 6 | 2023 |
| Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image … JM Bryant, RF Palm, R Herrera, M Rubens, SE Hoffe, DW Kim, A Kaiser, ... Cancer Control 30, 10732748221150228, 2023 | 4 | 2023 |
| Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer KE Mittauer, S Yarlagadda, JM Bryant, N Bassiri, T Romaguera, ... Radiotherapy and Oncology 188, 109869, 2023 | 2 | 2023 |
| Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: initial clinical experience T Kutuk, R Tolakanahalli, V Chaswal, S Yarlagadda, R Herrera, H Appel, ... Brachytherapy 22 (6), 872-881, 2023 | 2 | 2023 |
| OC-0415 long-term outcomes of MR-guided SABR & on-table adaptive replanning for Unresectable Pancreas cancer M Chuong, K Mittauer, T Romaguera, D Alvarez, R Kotecha, M Hall, ... | 2 | 2021 |
| Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases M Mills, R Kotecha, R Herrera, T Kutuk, M Fahey, E Wuthrick, GD Grass, ... Clinical and Translational Radiation Oncology 45, 100719, 2024 | 1 | 2024 |
| Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer A La Rosa, KE Mittauer, MD Chuong, MD Hall, T Kutuk, N Bassiri, ... Medical Dosimetry 48 (4), 238-244, 2023 | 1 | 2023 |
| Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy MD Hall, KE Mittauer, R Herrera, K Von Werne, R Kotecha, NS Kalman, ... Frontiers in Oncology 12, 1037674, 2023 | 1 | 2023 |
| Safety and feasibility of pancreas resection after a-smart in pancreatic cancer: Multicenter analysis N Lluis, R Herrera, F Kunzler, CL Wolfgang, S Aparo, F de-Zarraga, ... HPB 25, S129-S130, 2023 | 1 | 2023 |
| Management of Cardiac Implantable Electronic Devices for Patients Receiving MR-Guided Radiotherapy: 4-Year Single Institution Experience J McCulloch, R Herrera, A Gutierrez, T Romaguera, D Alvarez, R Kotecha, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), S95, 2022 | 1 | 2022 |
| Multi-institutional comparison of ablative radiation therapy in 5 versus 15-25 fractions for locally advanced pancreatic cancer M Reyngold, E O'Reilly, R Herrera, A Kaiser, M Zinovoy, PB Romesser, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), S106, 2022 | 1 | 2022 |
| Multi-institutional outcomes of patients aged 75 years and older with pancreatic ductal adenocarcinoma treated with ablative 5-fraction stereotactic magnetic resonance image … MD Chuong, R Palm, R Herrera, M Rubens, JM Bryant, SE Hoffe, DW Kim, ... Journal of Clinical Oncology 40 (4_suppl), 569-569, 2022 | 1 | 2022 |
| Cumulative Target Volume Dose and Locoregional Failure in Pancreatic Cancer Patients With Treated With Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) MD Chuong, R Herrera, S Chundru, A Gutierrez, T Romaguera, D Alvarez, ... International journal of radiation oncology, biology, physics 111 (3), S141, 2021 | 1 | 2021 |
| Ablative dose prescribed to oligometastases near gastrointestinal luminal structures is well tolerated using stereotactic magnetic resonance image-guided adaptive radiation … MD Chuong, R Herrera, J Contreras, R Kotecha, NS Kalman, J Garcia, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), e181, 2020 | 1 | 2020 |
Michael ChuongMiami Cancer InstituteVerified email at baptisthealth.net
